Skip directly to the search box, site navigation, or content.
Division of Foodborne, Bacterial and Mycotic Diseases (DFBMD)
Anthrax
Comprehensive CDC information about bioterrorism and related issues.
Related Internet Sites
CDC Emergency Preparedness and Response
CDC National Center for Infectious Diseases
References
Use of anthrax vaccine in the United States, Advisory Committee on Immunization Practices. MMWR 2000; 49 RR-15: 1-20, and Notice to Readers: Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR 2002; 45 RR-15: 1024-1026.
CDC. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001; 50: 909-919.
Hoffmaster AR, Meyer, RF, Bowen MB, et al. Evaluation and validation of real-time PCR assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002; 8: 1178-1181.
Hoffmaster A, Fitzgerald V, Ribot E, Mayer LW, Popovic T. Importance of molecular subtyping of Bacillus anthracis during recent-multi-state bioterrorism associated anthrax outbreak in the United States. Emerg Infect Dis 2002; 8: 1111-1116.
Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8: 1019-1028.
Quinn CP, Dull PM, Semenova V, Let al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 2004; 190(7): 1228-36.
Centers for Disease Control and Prevention. Inhalation anthrax associated with dried animal hides - Penbnsylvania and New York City, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 280-282.
Content Source: National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED)
Program Contents
Contact Information
